Stay updated with breaking news from Kessler Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Washington [US], May 30 (ANI): Exoskeleton therapy improves mobility, cognition and brain connectivity in people with multiple sclerosis (MS), according to the findings of a new study.
An international team of multiple sclerosis (MS) experts has identified four under-researched areas that are critical to advancing symptom management for progressive MS, recommending interdisciplinary collaboration among scientists, clinicians, industry leaders, and those with progressive MS.
E-Mail IMAGE: A research participant in the MS pilot study does exercise training in the Ekso NR at Kessler Foundation. view more Credit: Kessler Foundation/Jody Banks East Hanover, NJ. May 28, 2021. A team of multiple sclerosis (MS) experts at Kessler Foundation led the first pilot randomized controlled trial of robotic-exoskeleton assisted exercise rehabilitation (REAER) effects on mobility, cognition, and brain connectivity in people with substantial MS-related disability. Their results showed that REAER is likely an effective intervention, and is a promising therapy for improv...
Kessler Foundation East Hanover, NJ. May 28, 2021. A team of researchers has shown that physical intervention plans that included exoskeleton-assisted walking helped people with spinal cord injury evacuate more efficiently and improved the consistency of their stool. This finding was reported in Journal of Clinical Medicine on March 2, 2021, in the article “The Effect of Exoskeletal-Assisted Walking on Spinal Cord Injury Bowel Function: Results from a Randomized Trial and Comparison to Other Physical Interventions” (doi: 10.3390/jcm10050964). The authors are Peter H. Gorman, MD, of the Un...
E-Mail IMAGE: Dr. DeLuca, an expert in cognitive MS research, is senior vice president of Research and Training at Kessler Foundation. view more Credit: Kessler Foundation East Hanover, NJ. May 28, 2021. An international team of multiple sclerosis (MS) experts has identified four under-researched areas that are critical to advancing symptom management for progressive MS, recommending interdisciplinary collaboration among scientists, clinicians, industry leaders, and those with progressive MS. Their call to action was published in Multiple Sclerosis Journal on March 15, 2021, in th...